114 related articles for article (PubMed ID: 3902193)
1. The effect of iron dextran on ferritin content and 131I-antiferritin localization in experimental hepatomas.
Rostock RA; Kopher KA; Bauer TW; Klein JL
Cancer Drug Deliv; 1985; 2(1):3-9. PubMed ID: 3902193
[TBL] [Abstract][Full Text] [Related]
2. Factors that affect antiferritin localization in four rat hepatoma models.
Rostock RA; Kopher KA; Bauer TW; Klein JL
Cancer Drug Deliv; 1985; 2(2):139-45. PubMed ID: 3902194
[TBL] [Abstract][Full Text] [Related]
3. Distribution of and physiologic factors that affect 131I-antiferritin tumor localization in experimental hepatoma.
Rostock RA; Klein JL; Leichner PK; Order SE
Int J Radiat Oncol Biol Phys; 1984 Jul; 10(7):1135-41. PubMed ID: 6746354
[TBL] [Abstract][Full Text] [Related]
4. Variables affecting the tumor localization of 131I-antiferritin in experimental hepatoma.
Rostock RA; Klein JL; Kopher KA; Order SE
Am J Clin Oncol; 1984 Feb; 7(1):9-18. PubMed ID: 6695855
[TBL] [Abstract][Full Text] [Related]
5. Selective tumor localization in experimental hepatoma by radiolabeled antiferritin antibody.
Rostock RA; Klein JL; Leichner P; Kopher KA; Order SE
Int J Radiat Oncol Biol Phys; 1983 Sep; 9(9):1345-50. PubMed ID: 6885547
[TBL] [Abstract][Full Text] [Related]
6. Ferritin concentration and 131I-antiferritin tumor localization in an experimental hepatoma.
Klein JL; Kopher KA; Rostock RA
Int J Radiat Oncol Biol Phys; 1986 Jan; 12(1):137-40. PubMed ID: 3943985
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunotherapy of human hepatocellular carcinoma xenografts with 131I-labelled antiferritin antibody.
Saiful Alam AF
Br J Cancer; 1991 Apr; 63(4):503-7. PubMed ID: 2021533
[TBL] [Abstract][Full Text] [Related]
8. Dosimetry of 131I-labeled antiferritin in hepatoma: specific activities in the tumor and liver.
Leichner PK; Klein JL; Siegelman SS; Ettinger DS; Order SE
Cancer Treat Rep; 1983; 67(7-8):647-58. PubMed ID: 6307515
[TBL] [Abstract][Full Text] [Related]
9. Dosimetry and treatment planning for 90Y-labeled antiferritin in hepatoma.
Leichner PK; Yang NC; Frenkel TL; Loudenslager DM; Hawkins WG; Klein JL; Order SE
Int J Radiat Oncol Biol Phys; 1988 May; 14(5):1033-42. PubMed ID: 2834309
[TBL] [Abstract][Full Text] [Related]
10. Yttrium-90 and iodine-131 radioimmunoglobulin therapy of an experimental human hepatoma.
Klein JL; Nguyen TH; Laroque P; Kopher KA; Williams JR; Wessels BW; Dillehay LE; Frincke J; Order SE; Leichner PK
Cancer Res; 1989 Nov; 49(22):6383-9. PubMed ID: 2553255
[TBL] [Abstract][Full Text] [Related]
11. The theoretical implications and experimental and clinical results of radiolabeled antiferritin.
Order SE
Acta Oncol; 1990; 29(6):689-94. PubMed ID: 2223137
[TBL] [Abstract][Full Text] [Related]
12. Studies on ferritin in rat liver and spleen during repeated phlebotomy.
Mostert LJ; Cleton MI; de Bruijn WC; Koster JF; van Eijk HG
Int J Biochem; 1989; 21(1):39-47. PubMed ID: 2753199
[TBL] [Abstract][Full Text] [Related]
13. Antiferritin antibodies in immunoscintigraphic detection of human tumor xenografts.
Koprivová H; Novák F; Poucková P; Dvorák P; Seblová J; Svihovcová P; Dusková J; Pospísil J; Dienstbier Z
Int J Biol Markers; 1988; 3(3):159-64. PubMed ID: 3230335
[TBL] [Abstract][Full Text] [Related]
14. Effect of colchicine on the clearance of ferritin in vivo.
Ramm GA; Powell LW; Halliday JW
Am J Physiol; 1990 May; 258(5 Pt 1):G707-13. PubMed ID: 2333998
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of radiolabeled polyclonal antiferritin in patients with Hodgkin's disease.
Lai J; Quadri SM; Borchardt PE; Harris L; Wucher R; Askew E; Schweichel L; Vriesendorp HM
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3315s-3323s. PubMed ID: 10541380
[TBL] [Abstract][Full Text] [Related]
16. Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study.
Order SE; Stillwagon GB; Klein JL; Leichner PK; Siegelman SS; Fishman EK; Ettinger DS; Haulk T; Kopher K; Finney K
J Clin Oncol; 1985 Dec; 3(12):1573-82. PubMed ID: 2415692
[TBL] [Abstract][Full Text] [Related]
17. Comparative tumor dose from 131I-labeled polyclonal anti-ferritin, anti-AFP, and anti-CEA in primary liver cancers.
Leichner PK; Klein JL; Fishman EK; Siegelman SS; Ettinger DS; Order SE
Cancer Drug Deliv; 1984; 1(4):321-8. PubMed ID: 6085756
[TBL] [Abstract][Full Text] [Related]
18. Radiation enhancement of radiolabelled antibody deposition in tumors.
Msirikale JS; Klein JL; Schroeder J; Order SE
Int J Radiat Oncol Biol Phys; 1987 Dec; 13(12):1839-44. PubMed ID: 3679921
[TBL] [Abstract][Full Text] [Related]
19. The cellular transformation of injected colloidal iron complexes into ferritin and hemosiderin in experimental animals; a study with the aid of electron microscopy.
RICHTER GW
J Exp Med; 1959 Feb; 109(2):197-216. PubMed ID: 13620849
[TBL] [Abstract][Full Text] [Related]
20. Antiferritin IgG antibody for isotopic cancer therapy.
Order SE; Klein JL; Leichner PK
Oncology; 1981; 38(3):154-60. PubMed ID: 6259569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
